Measurement of Cholesterol and other Lipoprotein Constituents in the Clinical Laboratory
- 30 April 2000
- journal article
- review article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 38 (4) , 287-300
- https://doi.org/10.1515/cclm.2000.041
Abstract
Measurements of lipids and lipoproteins in the clinical laboratory have become increasingly important because of their predictive association with cardiovascular diseases, especially coronary artery disease. The US National Institutes of Health-sponsored National Cholesterol Education Program and counterparts in other countries have developed national consensus guidelines for diagnosis and treatment of coronary artery disease which provide risk cut-points and define use of the lipid/lipoprotein analytes in case finding and therapy. Total and low density lipoprotein cholesterol and triglycerides are measured as positive risk factors and high density lipoprotein cholesterol as an inverse risk factor for coronary artery disease. A National Cholesterol Education Program-sponsored expert laboratory panel has developed guidelines for measurements with requisite analytical performance targets for total error and corresponding precision and bias. The US Centers for Disease Control and Prevention have established reference methods for total and high density lipoprotein cholesterol and for triglycerides, with a method for low density lipoprotein cholesterol in development. Standardization programs for research laboratories and a Cholesterol Reference Method Laboratory Network for diagnostic manufacturers and clinical laboratories provide reliable access and documentation of traceability to accepted reference methods. Methods for the lipid/lipoprotein analytes have improved dramatically in recent years and, coupled with improved chemistry analyzer systems and more attention to standardization by manufacturers, offer considerable improvement in analytical performance. Fully automated homogeneous assays for high density lipoprotein cholesterol and newer similar assays for low-density lipoprotein cholesterol have potential for better precision as well as more convenient and cost-effective measurements. Attention to pre-analytical sources of variation is also important in making reliable classification of patients.Keywords
This publication has 19 references indexed in Scilit:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gelsClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart DiseasePublished by American Medical Association (AMA) ,1993
- Blood lipid measurements. Variations and practical utilityPublished by American Medical Association (AMA) ,1992
- Compact analysis systems for cholesterol, triglycerides and high-density lipoprotein cholesterolCurrent Opinion in Lipidology, 1991
- Is it time to measure apolipoprotein B?Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Determination of serum cholesterol by a modification of the isotope dilution mass spectrometric definitive methodAnalytical Chemistry, 1989
- Precipitation of Plasma Lipoproteins by PEG-6000 and Its Evaluation with Electrophoresis and UltracentrifugationScandinavian Journal of Clinical and Laboratory Investigation, 1976
- A comparison of heritable abnormal lipoprotein patterns as defined by two different techniquesJournal of Clinical Investigation, 1968
- Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérumClinica Chimica Acta; International Journal of Clinical Chemistry, 1960